4.2 Article

Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA

Journal

JOURNAL OF IMMUNOLOGICAL METHODS
Volume 505, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jim.2022.113275

Keywords

ELISA; COVID-19 vaccine; Peptide-based vaccine; SARS-CoV-2; Golden Syrian hamsters

Funding

  1. Mayo Clinic
  2. ICW Ventures for preclinical studies on a peptide-based COVID-19 vaccine

Ask authors/readers for more resources

This paper describes the development of an ELISA method for detecting antibodies specific to peptides and proteins derived from the SARS-CoV-2 virus in immunized golden Syrian hamsters. The method allows quantitative assessment of humoral immune responses at the peptide and protein levels, and has potential applications in the development and testing of peptide-based vaccines in hamsters.
Golden Syrian hamsters are increasingly used as a permissive animal model for SARS-CoV-2 virus studies, but the lack of immunological assays and other immunological reagents for hamsters limits its full potential. Herein, we developed an ELISA method to detect antibodies specific to peptides and proteins derived from SARS-CoV-2 virus in immunized golden Syrian hamsters. Under optimized conditions, this assay quantitates antibodies specific for individual viral peptides, peptide pools, and proteins. Hence, this ELISA method allows investigators to quantitatively assess humoral immune responses at the peptide and protein levels and has potential application in the development of peptide-based vaccines to be tested in hamsters.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available